Inventor
IVERSEN PATRICK L
US95 patents
⚠️ This page may combine multiple inventors who share the name “IVERSEN PATRICK L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AVI BIOPHARMA INC
20 patentsUS6677153B2Jan 13, 2004
Antisense antibacterial method and composition
AVI BIOPHARMA INC222 citations99
US7524829B2Apr 28, 2009
Antisense antiviral compounds and methods for treating a filovirus infection
AVI BIOPHARMA INC59 citations98
US7507196B2Mar 24, 2009
Antisense antiviral compounds and methods for treating a filovirus infection
AVI BIOPHARMA INC60 citations98
US7094765B1Aug 22, 2006
Antisense restenosis composition and method
AVI BIOPHARMA INC129 citations98
US7049431B2May 23, 2006
Antisense antibacterial cell division composition and method
AVI BIOPHARMA INC113 citations98
US6784291B2Aug 31, 2004
Splice-region antisense composition and method
AVI BIOPHARMA INC161 citations98
US6365351B1Apr 2, 2002
Non-invasive method for detecting target RNA
AVI BIOPHARMA INC120 citations98
US6365577B1Apr 2, 2002
p53 antisense agent and method
AVI BIOPHARMA INC80 citations98
US7888012B2Feb 15, 2011
Antisense composition and method for treating muscle atrophy
AVI BIOPHARMA INC56 citations97
US6841542B2Jan 11, 2005
Transforming growth factor beta (TGF-β) blocking agent-treated stem cell composition and method
AVI BIOPHARMA INC151 citations97
US8030291B2Oct 4, 2011
Antisense antiviral compounds and methods for treating a filovirus infection
AVI BIOPHARMA INC31 citations96
US8030292B2Oct 4, 2011
Antisense antiviral compounds and methods for treating a filovirus infection
AVI BIOPHARMA INC31 citations96
US7468418B2Dec 23, 2008
Compositions for enhancing transport of molecules into cells
AVI BIOPHARMA INC149 citations96
US7115583B2Oct 3, 2006
Microbubble compositions and methods for oligonucleotide delivery
AVI BIOPHARMA INC30 citations96
US7402574B2Jul 22, 2008
Antisense composition and method for treating cancer
AVI BIOPHARMA INC126 citations95
US6828105B2Dec 7, 2004
Antisense antiviral agent and method for treating ssRNA viral infection
AVI BIOPHARMA INC116 citations95
US7582615B2Sep 1, 2009
Antisense antiviral compound and method for treating arenavirus infection
AVI BIOPHARMA INC51 citations94
US7855283B2Dec 21, 2010
Antisense antiviral compound and method for treating arenavirus infection
AVI BIOPHARMA INC24 citations93
US8053420B2Nov 8, 2011
Peptide conjugated, inosine-substituted antisense oligomer compound and method
AVI BIOPHARMA INC15 citations92
US7807801B2Oct 5, 2010
Oligonucleotide analog and method for treating flavivirus infections
AVI BIOPHARMA INC28 citations92
IVERSEN PATRICK L
10 patentsUS8906872B2Dec 9, 2014
Antisense antiviral compound and method for treating ssRNA viral infection
IVERSEN PATRICK L36 citations98
US8877725B2Nov 4, 2014
Peptide conjugated, inosine-substituted antisense oligomer compound and method
IVERSEN PATRICK L49 citations97
US8436163B2May 7, 2013
Splice-region antisense composition and method
IVERSEN PATRICK L39 citations97
US8067569B2Nov 29, 2011
Splice-region antisense composition and method
IVERSEN PATRICK L52 citations97
US8785410B2Jul 22, 2014
Antisense composition and method for treating muscle atrophy
IVERSEN PATRICK L46 citations96
US8129352B2Mar 6, 2012
Antisense antiviral compound and method for treating ssRNA viral infection
IVERSEN PATRICK L34 citations96
US8084433B2Dec 27, 2011
Antisense antiviral compound and method for treating ssRNA viral infection
IVERSEN PATRICK L34 citations96
US8697858B2Apr 15, 2014
Antisense antiviral compound and method for treating influenza viral infection
IVERSEN PATRICK L40 citations94
US8618270B2Dec 31, 2013
Oligonucleotide analog and method for treating flavivirus infections
IVERSEN PATRICK L35 citations94
US8198429B2Jun 12, 2012
Antisense antiviral compounds and methods for treating a filovirus infection
IVERSEN PATRICK L17 citations93
UNIV NEBRASKA
9 patentsUS5849727ADec 15, 1998
Compositions and methods for altering the biodistribution of biological agents
UNIV NEBRASKA140 citations99
US6245747B1Jun 12, 2001
Targeted site specific antisense oligodeoxynucleotide delivery method
UNIV NEBRASKA104 citations98
US5457187AOct 10, 1995
Oligonucleotides containing 5-fluorouracil
UNIV NEBRASKA1,348 citations98
US5663321ASep 2, 1997
Oligonucleotide prodrugs containing 5-fluorouracil
UNIV NEBRASKA42 citations96
US5641754AJun 24, 1997
Antisense oligonucleotide compositions for selectively killing cancer cells
UNIV NEBRASKA92 citations96
US5614505AMar 25, 1997
Method of treating cancer with homo-oligonuleotides of 5-FU 5'-monophosphate
UNIV NEBRASKA37 citations96
US6686338B1Feb 3, 2004
Enzyme inhibitors for metabolic redirection
UNIV NEBRASKA21 citations93
US6673778B1Jan 6, 2004
Enzyme inhibitors for metabolic redirection
UNIV NEBRASKA16 citations93
US5643890AJul 1, 1997
Synthetic oligonucleotides which mimic telomeric sequences for use in treatment of cancer and other diseases
UNIV NEBRASKA70 citations93
SAREPTA THERAPEUTICS INC
4 patentsUS9416361B2Aug 16, 2016
Splice-region antisense composition and method
SAREPTA THERAPEUTICS INC90 citations98
US8895722B2Nov 25, 2014
Splice-region antisense composition and method
SAREPTA THERAPEUTICS INC86 citations98
US10533174B2Jan 14, 2020
Splice-region antisense composition and method
SAREPTA THERAPEUTICS INC31 citations97
US9249243B2Feb 2, 2016
Antibacterial antisense oligonucleotide and method
SAREPTA THERAPEUTICS INC13 citations92
STEIN DAVID A
4 patentsUS8524676B2Sep 3, 2013
Method for treating enterovirus or rhinovirus infection using antisense antiviral compounds
STEIN DAVID A39 citations94
US8785407B2Jul 22, 2014
Antisense antiviral agent and method for treating ssRNA viral infection
STEIN DAVID A38 citations92
US8759307B2Jun 24, 2014
Oligonucleotide compound and method for treating nidovirus infections
STEIN DAVID A35 citations92
US8168604B2May 1, 2012
Antisense antiviral compounds and methods for treating a filovirus infection
STEIN DAVID A29 citations92
WELLER DWIGHT D
2 patentsMOURICH DAN V
1 patentShowing the top 50 of 95 patents by PatentIndex Score.